FiberSense is the CxM Company. Headquartered in Switzerland, with R&D and manufacturing in Germany, we are building the next generation of continuous metabolic monitoring – starting with glucose and expanding towards continuous multi-analyte monitoring, or CxM. Building on the experience of EyeSense, a spin-off from CIBA Vision (Novartis Group), our proprietary photometric sensing platform powers a growing portfolio of products and applications across medical, lifestyle and professional care. Our first regulated application is the CE-marked FiberSense Continuous Glucose Monitoring (CGM) System for adults with diabetes. Combining 28-day wear with a reusable detector, it is planned for launch in 2027, with further applications already in development. Our ambition is to extend continuous sensing beyond glucose – making deeper metabolic insights more accessible, convenient and sustainable.
| Website | https://fibersense-cxm.com |
| Employees | 16 (5 on RocketReach) |
| Founded | 2006 |
| Industry | Medical Equipment Manufacturing |
Looking for a particular FiberSense employee's phone or email?
5 people are employed at FiberSense.
FiberSense is based in Basel, Basel City.